Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Career
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Learning
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Career
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Learning
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • Article

    Digitoxin in Patients with HFrEF May Improve Outcomes

    June 1, 2026

    Clinical question: In patients with chronic heart failure with reduced ejection fraction (HFrEF, defined as left ventricular ejection fraction of up to 40% with New York Heart Association class...

  • Article

    Fluid Restriction Does Not Improve Outcomes in HF Patients

    May 1, 2026

    Clinical question: Does a restrictive fluid strategy improve clinical outcomes in heart failure (HF) patients compared to liberal fluid intake? Background: Fluid restriction is often recommended for...

  • Article

    Liberal or Restrictive Postoperative Transfusion in Patients at High Cardiac Risk: The TOP Randomized Clinical Trial

    May 1, 2026

    Clinical question: Does a liberal transfusion strategy decrease the risk of death or major ischemic events after major surgical operations in patients at high risk of cardiac events? Background:...

  • Article

    Anticoagulation and Antiplatelet Therapy in Patients with AF and Atherosclerosis

    April 6, 2026

    CLINICAL QUESTION: In patients with atherosclerotic disease and concurrent atrial fibrillation, does adding antiplatelet therapy to oral anticoagulation improve net clinical outcomes compared with...

  • Article

    Impact of Long-Term Beta-Blocker Therapy on Death and Recurrent MI in Patients with Acute MI with Preserved Ejection Fraction

    April 6, 2026

    CLINICAL QUESTION: Does therapy with a beta-blocker reduce mortality and myocardial infarction (MI) in patients with a recent myocardial infarction with preserved ejection fraction? BACKGROUND: The...

  • Article

    Caffeinated Coffee Consumption Reduces AF Recurrence After Electrical Cardioversion

    April 6, 2026

    CLINICAL QUESTION: What effect does coffee consumption have on atrial fibrillation (AF) after successful electrical cardioversion? BACKGROUND: Coffee is one of the most-consumed beverages, and it...

  • Article

    Comparative Efficacy and Safety of Clopidogrel Versus Aspirin Monotherapy in Patients with Established CAD

    April 6, 2026

    CLINICAL QUESTION: Does monotherapy with clopidogrel reduce the risk of major adverse cardiovascular or cerebrovascular events (MACCE) compared to monotherapy with aspirin in patients with...

  • Article

    Invasive Versus Conservative Strategy in Older Adults with NSTE-ACS: Fewer Infarctions Without a Mortality Benefit

    April 6, 2026

    CLINICAL QUESTION: In patients aged 70 years or older with non–ST-segment elevation acute coronary syndrome (NSTEACS), does an invasive strategy reduce mortality and cardiovascular events compared...

  • Article

    Influenza Vaccination Improves All-Cause Mortality and Rates of Readmission for Patients Admitted with Acute HF

    March 2, 2026

    CLINICAL QUESTION: Does influenza vaccination prior to hospital discharge improve a cause mortality and rates of readmission for patients admitted with acute heart failure (HF)? BACKGROUND:...

  • Article

    Impact of Cardiopulmonary POCUS on Hospital LOS in Patients with Undifferentiated Dyspnea

    March 2, 2026

    CLINICAL QUESTION: Is cardiopulmonary point-of-care ultrasonography (POCUS) associated with reduced hospital lengths of stay (LOS) in patients with undifferentiated dyspnea? BACKGROUND: POCUS has...

1 2 3 … 82Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • Cookie Preferences